This Study is to Evaluate Whether Receiving Education and Glucose Monitoring With the CGM Device Will Improve Patient-reported Outcomes by Improving Patient's Satisfaction and Quality of Life (QOL) With Glucose Monitoring Device
RecruitingObservational study
Continuous Glucose Monitor (CGM) Discharge Program
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * aged 18 or older * diagnosed with Type 1 or Type 2 Diabetes who are on insulin * able to speak and understand English language * scheduled to receive a standard inpatient diabetes education consultation * must not have used CGM in the six months prior to admission * owns a smartphone * demonstrates the ability to follow instructions and be capable of providing informed consent to participate in the program Exclusion Criteria: * those who are known to be pregnant. This is due to complexity of pregnancy-related changes in glucose metabolism and increased skin sensitivity, or changes in skin condition to adhesives and materials used in CGM devices. * non-English speakers. As this is small study to evaluate which method is favorable using a survey only validated in English, enrolling non-English speakers would require additional resources/translations/personnel for evaluation and the education intervention that are not logistically possible right now.
About the study
The purpose of the study is to improve patient-reported outcomes by improving patient's satisfaction and quality of life (QOL) with glucose monitoring device through pre and post satisfaction survey of patient with diabetes.
Sponsor: Cedars-Sinai Medical Center · Participants: 37 · Started: Oct 1, 2025
Contact the study team
- Mathew P Monterola, Doctor of Nursing Practice · Phone: 3109677434
Official record on ClinicalTrials.gov — NCT06965803
Locations in the U.S.
| California | Cedars-Sina Medical Center, Los Angeles |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.